
Wockhardt Q2 Results 2025 Highlights: Net Profit Rose by 454.55% & Revenue Down 3.34% YoY
Posted by : sachet | Tue Nov 04 2025

Click and Sign Up to Get Live Updates on Q2 Results
Wockhardt Q2 Results FY26: During Q2 FY26, Wockhardt’s profit increased 454.55% YoY, while revenue decreased by 3.34% YoY. The company posted robust numbers, with Q2 PAT at ₹78.00 crores and revenue at ₹782.00 crores. Wockhardt showed its Q2 results on 3rd November 2025.
Wockhardt Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30th Sep 2025 | 30 Sept 2024 | |
| Revenue from Operations | ₹782.00 | ₹809.00 | 
| Profit Before Tax (PBT) | ₹199.00 | ₹119.00 | 
| Profit After Tax (PAT) | ₹78.00 | -₹22.00 | 
(Figures in crores)
Wockhardt Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-09-2025 | 30-09-2024 | |
| Revenue from Operations | ₹380.00 | ₹370.00 | 
| Profit Before Tax (PBT) | ₹143.00 | ₹60.00 | 
| Profit After Tax (PAT) | ₹54.00 | -₹36.00 | 
(Figures in crores)
Wockhardt Q2 Results FY26 Highlights (Q2 FY26 vs FY25)
- Wockhardt clocked Q2 FY26 consolidated revenue of ₹782.00 crores vs ₹809.00 crores.
 - On the profit front, Wockhardt earned a consolidated PAT of ₹78.00 crore in Q2 FY26. During FY25, the company’s PAT stood at -₹22.00 crore.
 - According to the consolidated figures, Wockhardt’s quarterly PAT increased by 454.55% YoY, while revenue decreased by 3.34%.
 - Wockhardt clocked Q2 FY26 standalone revenue of ₹380.00 crores vs ₹370.00 crores.
 - On the profit front, Wockhardt earned a standalone PAT of ₹54.00 crore in Q2 FY26. During FY25, the company’s PAT stood at -₹36.00 crore.
 - According to the standalone figures, Wockhardt’s quarterly PAT increased by 250.00% YoY, while revenue increased by 2.70%.
 
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
About Wockhardt Limited
Wockhardt is a global pharmaceutical and biotechnology company that provides affordable, high-quality medicine and healthcare services. The company Manufactures and markets branded and generic drugs, including finished dosage formulations, injectables, biopharmaceuticals, orals, and topicals. The company operates in the pharmaceutical, biotechnology, and a chain of super-speciality hospitals. The company has a significant international presence, with 83% of its revenue coming from markets outside India, including the USA, Europe, and India.
Wockhardt Share Price Performance
On the opening bell on 4th November 2025, Wockhardt shares opened at ₹1,403.00 per share. However, the initial gains have since eroded, and Wockhardt shares are currently trading at ₹1,381.60 per share, which is lower than the opening price.
Considering the long-term achievements, Wockhardt shares have yielded returns of approximately 6.66% over the past 6 months, and 1-year returns stand at 5.42%. Over the maximum timeframe, Wockhardt shares delivered a 488.35% return to investors.
What Analysts Expect Post Q2 Results?
Following Wockhardt’s robust Q2 results, analysts expect its share price to rise. According to analysts, Wockhardt’s share price could reach ₹1,460.20 per share in the coming year and, in a downturn, could fall to ₹ 1,355.30 per share. However, one must ignore stock market volatility and invest in Wockhardt’s shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY
Inspira Enterprise India IPO Details: Everything You Should Know about
Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY
HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY
BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here
Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here
Related Posts
Timken India Q2 Results 2025 Highlights: Net Profit Falls by 89.47% & Revenue Up 2.67% YoY
City Union Bank Q2 Results 2025 Highlights: Net Profit Peaked 15.22% & Revenue Up 1,912.26% YoY
Hitachi Energy Q2 Results 2025 Highlights: Net Profit Rose by 405.57% & Revenue Up 17.94% YoY
Gland Pharma Q2 Results 2025 Highlights: Net Profit Surged by 12.32% & Revenue Up 5.76% YoY
Bharti Hexacom Q2 Results 2025 Highlights: Net Profit Rose by 66.42% & Revenue Up 10.47% YoY

